Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3988933 | 0.83 | NFKB1 (0.33) | NFKB1NFKB2RELA | |
| SCHEMBL918872 | 0.83 | NFKB1 (0.33) | NFKB1NFKB2RELA | |
| SCHEMBL31473481 | 0.77 | SLC2A1 (0.37) | NFKB1NFKB2RELA | |
| SCHEMBL12775465 | 0.76 | LMNA (0.32) | CES2LMNA | |
| SCHEMBL17918196 | 0.75 | NFKB1 (0.39) | NFKB1NFKB2RELA | |
| SCHEMBL4790845 | 0.72 | — | — | |
| SCHEMBL3983475 | 0.69 | — | — | |
| SCHEMBL681879 | 0.69 | — | — | |
| SCHEMBL767441 | 0.69 | — | — | |
| SCHEMBL3014862 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545694-B2 | Cannabidiol derivatives, preparation method thereof and use thereof | CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) | 2026-02-10 | — | — | US | disclosed |
| EP-4088723-B1 | CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | CHENGDU BAIYU PHARMACEUTICAL CO LTD (CN) | 2025-08-06 | — | — | EP | disclosed |
| CN-113087741-B | Cannabidiol derivative, preparation method and medical application thereof | 成都百裕制药股份有限公司 | 2023-04-28 | — | — | CN | disclosed |
| US-20230059087-A1 | CANNABIDIOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF | CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) | 2023-02-23 | — | — | US | disclosed |
| US-20230059087-A1 | CANNABIDIOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF | CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) | 2023-02-23 | — | — | US | disclosed |
| US-20230002425-A1 | CANNABIDIOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF | CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) | 2023-01-05 | — | — | US | disclosed |
| EP-4089084-A1 | CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Chengdu Baiyu Pharmaceutical Co., Ltd. (CN) | 2022-11-16 | — | — | EP | disclosed |
| EP-4088723-A1 | CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Chengdu Baiyu Pharmaceutical Co., Ltd. (CN) | 2022-11-16 | — | — | EP | disclosed |
| EP-4089084-A1 | CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Chengdu Baiyu Pharmaceutical Co., Ltd. (CN) | 2022-11-16 | — | — | EP | disclosed |
| WO-2021139739-A1 | CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 成都百裕制药股份有限公司 | 2021-07-15 | — | — | WO | disclosed |
| WO-2021139741-A1 | CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 成都百裕制药股份有限公司 | 2021-07-15 | — | — | WO | disclosed |
| WO-2021139741-A1 | CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 成都百裕制药股份有限公司 | 2021-07-15 | — | — | WO | disclosed |
| WO-2021139739-A1 | CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 成都百裕制药股份有限公司 | 2021-07-15 | — | — | WO | disclosed |
| CN-113087599-A | Cannabidiol derivative, preparation method and medical application thereof | 成都百裕制药股份有限公司 | 2021-07-09 | — | — | CN | disclosed |
| CN-113087741-A | Cannabidiol derivative, preparation method and medical application thereof | 成都百裕制药股份有限公司 | 2021-07-09 | — | — | CN | disclosed |
| EP-2314580-B1 | Method for producing synthetic cannabinoids | HEALTH CONCEPT GMBH (DE) | 2015-09-09 | — | — | EP | disclosed |
| EP-2314580-A1 | Method for producing synthetic cannabinoids | The Health Concept GmbH (DE) | 2011-04-27 | — | — | EP | disclosed |
| US-20100298579-A1 | Process for preparing synthetic cannabinoids | THC PHARM GMBH (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100298579-A1 | Process for preparing synthetic cannabinoids | THC PHARM GMBH (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100298579-A1 | Process for preparing synthetic cannabinoids | THC PHARM GMBH (DE) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545694-B2 | Cannabidiol derivatives, preparation method thereof and use thereof | CNR1, CNR2, OPRM1 | NFKB1 4354/4885NFKB2 3821/4885RELA 3792/4885 |
| US-20230002425-A1 | CANNABIDIOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF | CNR1, CNR2, CYP2B6 | NFKB1 4621/4885NFKB2 4691/4885RELA 3674/4885 |
| US-20230059087-A1 | CANNABIDIOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF | CNR1, CNR2, UGT2B7 | NFKB1 4630/4885NFKB2 4629/4885RELA 3579/4885 |
| US-20100298579-A1 | Process for preparing synthetic cannabinoids | CNR2, CNR1, FAAH | NFKB1 4018/4885NFKB2 4497/4885RELA 4676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.